학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 1,204건 | 목록 1~20
Academic Journal
Cloughesy T; Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California; and.; Nathanson DA; Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California; and.; Czernin J; David Geffen School of Medicine at UCLA, Los Angeles, California.
Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE; In Process
Academic Journal
Whittle JR; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Vieito M; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.; Rohrberg K; Department of Oncology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.; Rodriguez-Ruiz ME; Oncology, Clinica Universidad de Navarra, Pamplona, Spain.; Castanon E; Oncology, Clinica Universidad de Navarra, Pamplona, Spain.; Mellinghoff IK; Department of Neurology and Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, USA.; Van Linde M; Department of Medical Oncology, Amsterdam University Medical Center, location VU Medical Center, Amsterdam, The Netherlands.; Cloughesy T; Department of Neurology, Ronald Reagan UCLA Medical Center, University of California, Los Angeles, California, USA.; Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Chong RA; Department of Neurology, Ronald Reagan UCLA Medical Center, University of California, Los Angeles, California, USA.; Rosenthal M; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Wick A; Department of Neurology and Neurooncology Program, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; Waldhauer I; Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland.; Henkel N; Roche Pharma Research and Early Development, Early Clinical Development Oncology, Roche Innovation Center Munich, Germany.; Romagnoli B; Roche Pharma Research and Early Development, Early Clinical Development Oncology, Roche Innovation Center Basel, Switzerland.; Wolowski V; Roche Pharma Research and Early Development, Early Clinical Development Oncology, Roche Innovation Center Basel, Switzerland.; Dey S; Roche Products Ltd, Welwyn Garden City, UK.; Heil F; Roche Pharma Research and Early Development, Early Clinical Development Oncology, Roche Innovation Center Munich, Germany.; Heichinger C; Roche Pharma Research and Early Development, Early Clinical Development Oncology, Roche Innovation Center Basel, Switzerland.; Flinn N; Roche Products Ltd, Welwyn Garden City, UK.; Gou JP; Roche Pharma Research and Early Development, Early Clinical Development Oncology, Roche Innovation Center Basel, Switzerland.; Smith L; Roche Products Ltd, Welwyn Garden City, UK.; Prince F; Roche Pharma Research and Early Development, Early Clinical Development Oncology, Roche Innovation Center Basel, Switzerland.; Derks M; Roche Products Ltd, Welwyn Garden City, UK.; Roller A; Roche Pharma Research and Early Development, Early Clinical Development Oncology, Roche Innovation Center Basel, Switzerland.; Schiff C; Roche Pharma Research and Early Development, Early Clinical Development Oncology, Roche Innovation Center Basel, Switzerland.; Schneider M; Roche Pharma Research and Early Development, Early Clinical Development Oncology, Roche Innovation Center Basel, Switzerland.; Mason W; Department of Medicine, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE
Academic Journal
Lee AH; Department of Neurosurgery, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; Sun L; Department of Neurosurgery, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; Mochizuki AY; Department of Neurosurgery, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; Reynoso JG; Department of Neurosurgery, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; Orpilla J; Department of Neurosurgery, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; Chow F; Department of Neurology/Neuro-Oncology, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; Kienzler JC; Department of Neurosurgery, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; Everson RG; Department of Neurosurgery, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; UCLA Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; Nathanson DA; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; UCLA Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; Bensinger SJ; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; UCLA Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; Liau LM; Department of Neurosurgery, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; UCLA Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; Cloughesy T; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; Department of Neurology/Neuro-Oncology, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; UCLA Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; Hugo W; UCLA Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, 90095, USA. HWilly@mednet.ucla.edu.; Parker Institute for Cancer Immunotherapy, 1 Letterman Drive, Suite D3500, San Francisco, CA, 94129, USA. HWilly@mednet.ucla.edu.; Department of Medicine/Dermatology, University of California, Los Angeles, Los Angeles, CA, 90095, USA. HWilly@mednet.ucla.edu.; Prins RM; Department of Neurosurgery, University of California, Los Angeles, Los Angeles, CA, 90095, USA. RPrins@mednet.ucla.edu.; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, 90095, USA. RPrins@mednet.ucla.edu.; UCLA Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, 90095, USA. RPrins@mednet.ucla.edu.; Parker Institute for Cancer Immunotherapy, 1 Letterman Drive, Suite D3500, San Francisco, CA, 94129, USA. RPrins@mednet.ucla.edu.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Le Rhun E; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland.; Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.; Sain D; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.; Erridge SC; Edinburgh Cancer Centre, University of Edinburgh, Edinburgh, United Kingdom.; Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Minniti G; Department of Radiological Sciences, Oncology and Anatomical Pathology, Sapienza University of Rome, Rome, Italy.; Policlinico Umberto I, Rome, Italy.; Roth P; Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.; Wick W; Department of Neurology and European Center for Neurooncology, University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Neuro-Oncology, German Cancer Research Center and German Consortium for Translational Cancer Research, Heidelberg, Germany.; Nabors B; Department of Neurology, University of Alabama at Birmingham, Birmingham.; Sampson J; Department of Neurosurgery, Duke University Medical Center, Preston Robert Tisch Brain Tumor Center at Duke, Durham, North Carolina.; Mason W; Department of Medicine, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.; Cloughesy T; Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles.; Reijneveld JC; Department of Neurology & Brain Tumor Center Amsterdam, Amsterdam University Medical Center, Amsterdam, the Netherlands.; Department of Neurology, Stichting Epilepsie Instellingen Nederland, Heemstede, the Netherlands.; Stupp R; Lou and Jean Malnati Brain Tumor Institute, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.; Preusser M; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.; Gorlia T; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.; Weller M; Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.
Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE
Academic Journal
van den Bent MJ; The Brain Tumor Center at Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Vogelbaum MA; Department of NeuroOncology, Moffitt Cancer Center, Tampa, Florida, USA.; Cloughesy T; Department of Neurology, UCLA, California, USA.; Galldiks N; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Germany.; Institute of Neuroscience and Medicine (INM-3), Research Center Juelich, Juelich, Germany.; Department of Neurology, Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany.; Albert NL; Department of Nuclear Medicine, LMU University Hospital of Munich, Munich, Germany.; Tonn JC; German Cancer Consortium (DKTK), Partner site Munich, Germany.; Department. of Neurosurgery, University Hospital of Munich (LMU), Munich, Germany.; Avila E; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, USA.; Fangusaro J; Children's Healthcare of Atlanta, Emory University, and the Aflac Cancer Center, Atlanta, Georgia, USA.; Mirsky D; Department of Radiology, Pediatric Section, University of Colorado School of Medicine, Children's Hospital Colorado, Colorado, USA.; Sahgal A; Sunnybrook Odette Cancer Center, University of Toronto, Toronto, Ontario, Canada.; Soffietti R; Division of Neuro-Oncology, Department of Neuroscience 'Rita Levi Montalcini,' University of Turin, Turin, Italy.; Karschnia P; Department of Neurosurgery, University Hospital Erlangen, Friedrich-Alexander University, Erlangen, Germany.; German Cancer Consortium (DKTK), Partner site Munich, Germany.; Department. of Neurosurgery, University Hospital of Munich (LMU), Munich, Germany.; Mehta M; Miami Cancer Institute at Baptist Health of South Florida & Florida International University Department of Radiation Oncology, Miami, Florida, USA.; Kim MM; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA.; Boele F; Leeds Institute of Health Sciences, Faculty of Medicine and Health, University of Leeds, Leeds, UK.; Leeds Institute of Medical Research at St James's, St James's University Hospital, University of Leeds, Leeds, UK.; Huse JT; Departments of Pathology and Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Nayak L; Center for Neuro-Oncology, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, Massachusetts, USA.; Lim-Fat MJ; Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.; le Rhun E; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.; Desjardins A; The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University, Durham, North Carolina, USA.; Lee EQ; Center for Neuro-Oncology, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, Massachusetts, USA.; Chukwueke U; Center for Neuro-Oncology, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, Massachusetts, USA.; Koekkoek JAF; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.; Mendoza T; Office of Patient-Centered Outcomes Research, Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, Maryland, USA.; Loughan AR; Department of Neurology, Division of Neuro-Oncology, Virginia Commonwealth University, Richmond, Virginia, USA.; Budhu JA; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, USA.; Bakas S; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA.; Division of Computational Pathology, Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.; Huang RY; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Villanueva-Meyer JE; Neurological Surgery at University of California, San Francisco, California, USA.; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California, USA.; Leone JP; Department of Medical Oncology, Brigham and Women's Hospital Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Okada H; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Neurological Surgery at University of California, San Francisco, California, USA.; Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, Massachusetts, USA.; Bi WL; Department of Neurosurgery Department of Neurosurgery, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.; Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, Massachusetts, USA.; Chang SM; Division of NeuroOncology, Department of Neurological Surgery, University of California San Francisco (UCSF), San Francisco, California, USA.
Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE
Conference
1996 IEEE Nuclear Science Symposium. Conference Record Nuclear science and medical imaging Nuclear Science Symposium, 1996. Conference Record., 1996 IEEE. 3:1859-1862 vol.3 1996
Academic Journal
IEEE Transactions on Nuclear Science IEEE Trans. Nucl. Sci. Nuclear Science, IEEE Transactions on. 44(6):2522-2526 Dec, 1997
검색 결과 제한하기
제한된 항목
[검색어] Cloughesy T
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어